The pharmacy at the center of a national fungal meningitis outbreak shipped products to Allina Medical Clinic-Shakopee and St. Francis Regional Medical Center in Shakopee, according to the U.S. Federal Drug Administration (FDA).
The products were not the injectible steroids that the FDA blames for causing the infections that has killed 24 people in 18 states, according to the Centers for Disease Control and Prevention. The FDA said it was alerting all customers of the New England Compounding Center (NECC) of Framingham, MA out of "an abundance of caution."
The clinic and medical center are the second and third facilities in Shakopee the FDA identified as having received NECC products. Medical Advanced Pain Specialists (MAPS), with a location at the St. Francis Regional Medical Center campus, is one of six clinics in Minnesota that administered what turned out to be tainted NECC steroid treatment for back pain. MAPS also appears on the FDA list, which includes all clinics that were shipped NECC products since May 21, 2012.
The Minnesota Department of Health (MDH) announced the Minnesota's eighth and ninth cases of fungal meningitis on Thurs., Oct. 25. Both are men, one in his 50s, the other in his 60s. The agency has not said where the patients live or which clinic gave them the steroid shots that caused the infection.
No one in Minnesota has died of the rare infection, which is different from the more common bacterial and viral forms of meningitis and cannot be spread person-to-person.
According to the FDA, here are the products shipped to Allina Medical Clinic and St. Francis Regional Medical Center:
NAME OF CLINIC
PRODUCT FROM NECC COMPOUNDING PHARMACY SHIPPED TO CLINICS
ALLINA MEDICAL CLINIC
HYDROXYPROGESTERONE CAPROATE 250MG/ML 5ML
Seven dates from June 12 to Oct.1
ST. FRANCIS REGIONAL MEDICAL CENTER
SULPHAN BLUE (PF) 1% INJECTABLE, 5ML VIAL
July 10 and Sept. 27
Minnesota Department of Health spokesperson Doug Schultz said the agency had asked the more than 100 Minnesota clinics on the list to contact patients that might have received treatments with products from NECC.